No. |
Product Name |
CAS No. |
Spec |
Price |
|
| LG-0106 |
Gabapentin ≥98% |
60142-96-3 |
| 10 mg |
Inquiry |
| 50 mg |
Inquiry |
| 250 mg |
Inquiry |
|
|
| LG-0246 |
Galantamine Hydrobromide ≥98% |
1953-04-4 |
| 5 mg |
Inquiry |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
| LG-4535 |
Glimepiride ≥98% |
93479-97-1 |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LG-4634 |
Glipizide ≥98% |
29094-61-9 |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LG-5874 |
Gossypol ≥98% |
303-45-7 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
| 250 mg |
Inquiry |
|
|
| LG-8101 |
Guaifenesin ≥98% |
93-14-1 |
| 25 g |
Inquiry |
| 100 g |
Inquiry |
| 500 g |
Inquiry |
|
|
| LH-1894 |
Hexestrol ≥98% |
84-16-2 |
|
|
| LH-9801 |
Hyaluronic Acid Sodium Salt ≥95% |
9067-32-7 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LH-9763 |
Hypoxanthine ≥98% |
68-94-0 |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
| 100 g |
Inquiry |
|
|
| LI-1418 |
Idebenone ≥98% |
58186-27-9 |
| 10 mg |
Inquiry |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
| LI-5034 |
Imiquimod >99.5% |
99011-02-6 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LI-5414 |
Indapamide ≥98% |
26807-65-8 |
| 250 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LI-5830 |
Iohexol ≥98% |
66108-95-0 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LI-7074 |
Irsogladine Maleate ≥98% |
84504-69-8 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LI-7302 |
Isatin ≥97% |
91-56-5 |
| 100 g |
Inquiry |
| 500 g |
Inquiry |
|
|
| LI-7259 |
Isoproterenol Hydrochloride ≥98% |
51-30-9 |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
| 100 g |
Inquiry |
|
|
| LI-7360 |
Isosorbide Mononitrate ≥98% |
16051-77-7 |
| 5 g |
Inquiry |
| 10 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LI-7757 |
Itopride Hydrochloride ≥98% |
122892-31-3 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LI-8618 |
Ivermectin ≥95% |
70288-86-7 |
|
|
| LL-0226 |
Lagochiline ≥98% |
|
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
